- Home
- IIIN vs DAWN Comparison
IIIN vs DAWN Comparison
Compare IIIN & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIIN
- DAWN
- Stock Information
- Founded
- IIIN 1953
- DAWN 2018
- Country
- IIIN United States
- DAWN United States
- Employees
- IIIN N/A
- DAWN N/A
- Industry
- IIIN Steel/Iron Ore
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- IIIN Industrials
- DAWN Health Care
- Exchange
- IIIN Nasdaq
- DAWN Nasdaq
- Market Cap
- IIIN 712.0M
- DAWN 624.8M
- IPO Year
- IIIN N/A
- DAWN 2021
- Fundamental
- Price
- IIIN $38.22
- DAWN $6.99
- Analyst Decision
- IIIN
- DAWN Strong Buy
- Analyst Count
- IIIN 0
- DAWN 7
- Target Price
- IIIN N/A
- DAWN $27.86
- AVG Volume (30 Days)
- IIIN 86.0K
- DAWN 922.7K
- Earning Date
- IIIN 10-16-2025
- DAWN 10-29-2025
- Dividend Yield
- IIIN 2.91%
- DAWN N/A
- EPS Growth
- IIIN 53.01
- DAWN N/A
- EPS
- IIIN 1.59
- DAWN N/A
- Revenue
- IIIN $604,566,000.00
- DAWN $187,638,000.00
- Revenue This Year
- IIIN $24.62
- DAWN $12.56
- Revenue Next Year
- IIIN $7.01
- DAWN $48.02
- P/E Ratio
- IIIN $24.21
- DAWN N/A
- Revenue Growth
- IIIN 9.44
- DAWN 2190.50
- 52 Week Low
- IIIN $22.49
- DAWN $5.64
- 52 Week High
- IIIN $41.64
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- IIIN 51.24
- DAWN 46.39
- Support Level
- IIIN $37.99
- DAWN $6.90
- Resistance Level
- IIIN $39.56
- DAWN $7.58
- Average True Range (ATR)
- IIIN 0.88
- DAWN 0.26
- MACD
- IIIN -0.07
- DAWN -0.07
- Stochastic Oscillator
- IIIN 35.50
- DAWN 10.78
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.